Interleukin-10 in viral diseases and cancer: exiting the labyrinth? (Q35951835)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Interleukin-10 in viral diseases and cancer: exiting the labyrinth?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Interleukin-10 in viral diseases and cancer: exiting the labyrinth? (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

author name string

Alain P Vicari

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Giorgio Trinchieri

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Immunological Reviews

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

202

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

223-236

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

The dual role of IL-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Interleukin 10 secretion in relation to human IL-10 locus haplotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

An investigation of polymorphism in the interleukin-10 gene promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

TIR domain-containing adaptors define the specificity of TLR signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Murine retroviruses activate B cells via interaction with toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

A single amino acid determines the immunostimulatory activity of interleukin 10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Regulatory activity of autocrine IL-10 on dendritic cell functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Tumor suppressor activity of the TGF-beta pathway in human cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Role of transforming growth factor-beta signaling in cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.0105-2896.2004.00216.X

21 January 2018

Identifiers

10.1111/J.0105-2896.2004.00216.X

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35951835&oldid=1981004053"